CCRC and ACRP-CP Practice Questions: Five Original GCP Scenarios

Good CCRC and ACRP-CP practice questions ask you to apply a rule to a particular responsibility. These five original scenarios cover consent, safety reporting, records, protocol compliance, and sponsor oversight. They are written for study, are not recalled examination items, and do not reproduce or predict ACRP questions.

Sources and dates verified October 15, 2026. Each explanation identifies its basis in ICH E6(R3), Principles and Annex 1. The questions share foundational GCP concepts; they are not a complete representation of either credential's official examination outline.

CCRC and ACRP-CP test different professional scopes

CCRC means Certified Clinical Research Coordinator. It focuses on coordination responsibilities under a principal investigator. ACRP-CP means ACRP Certified Professional and spans clinical research functions across job roles. Neither is automatically a higher level of the other.

ACRP's handbook distinguishes qualifying CRC work for CCRC from work aligned with the ACRP-CP outline. Both have experience requirements, with specified substitution pathways. Confirm your eligibility with ACRP before interpreting practice performance as readiness to apply.

Use the CCRC practice page or ACRP-CP practice page for your selected credential. If comparing organizations, the SOCRA CCRP page provides another starting point, but its reference scope differs.

Confirm the examination window before planning

ACRP's spring 2026 testing period was February 15–May 15; regular registration closed April 30. Its fall 2026 testing window runs July 15–October 15, with regular registration ending September 30.

Today, October 15, is the published final day of that fall window. The testing end date does not reopen registration. New applicants should verify ACRP's next published calendar; this article does not confirm 2027 dates.

ACRP changed all certification examinations to E6(R3) on July 15, 2026. Its handbook describes an ICH-based examination rather than testing country-specific regulations. The cases below therefore state their GCP basis explicitly.

Question 1: Consent before a trial-specific procedure

An adult with decision-making capacity arrives for screening. The consent discussion is complete, but the participant has not signed or dated the form. A coordinator suggests collecting a blood sample required only by the trial while the participant finishes reading. No emergency exception applies. What is the best action?

A. Collect the sample because the discussion already occurred.

B. Complete and document valid consent before the trial-specific blood draw.

C. Ask the investigator to sign for the participant.

D. Collect the sample and request a signature dated to the arrival time.

Best answer: B. ICH E6(R3), Annex 1 section 2.8.7, requires the appropriate signatures and dates before trial participation in this situation.

• A is incorrect because discussion alone does not complete the required documentation here.
• B respects the participant's decision and the timing requirement before the research procedure.
• C is incorrect because investigator responsibility does not authorize signing on behalf of a capable participant.
• D is incorrect because a later signature does not retrospectively authorize the procedure, and backdating misrepresents the record.

The decisive facts are that the blood draw is trial-specific and no exception applies. Do not assume every routine clinical procedure is a research intervention.

Question 2: A serious adverse event with incomplete records

An investigator learns that a trial participant was hospitalized overnight. The investigator assesses the event as serious; it is not a protocol-defined exception to immediate reporting. The discharge summary is unavailable. What is the best initial reporting action?

A. Wait until the discharge summary confirms every detail.

B. Wait fifteen days because all serious events use that deadline.

C. Report immediately to the sponsor with the available information and a causality assessment, then follow up.

D. Notify only the IRB and assume it will inform the sponsor.

Best answer: C. Annex 1 section 2.7.2(b) addresses immediate investigator-to-sponsor SAE reporting after reasonable awareness, including causality assessment and subsequent follow-up information.

• A improperly delays the initial report while complete information is gathered.
• B confuses different reporting relationships and invents a universal deadline.
• C follows the stated GCP duty while allowing later supporting information.
• D substitutes another communication route for the investigator's sponsor-reporting responsibility.

Other required communications must also be assessed. This answer does not imply that a sponsor report automatically satisfies every IRB or regulatory obligation.

Question 3: Correcting an electronic source record

A delegated staff member discovers a transposed value in an electronic source record. The correct value is supported by the original laboratory report. Which correction best supports data integrity?

A. Delete the record and create a replacement with no history.

B. Ask a colleague to make the change under the colleague's account.

C. Leave the error because source records can never be corrected.

D. Make an authorized, traceable correction that preserves the original entry and explains the change where necessary.

Best answer: D. Annex 1 section 2.12.2 requires traceable source-record changes that do not obscure the original entry.

• A removes the history needed to reconstruct what happened.
• B misattributes the correction and weakens accountability.
• C is incorrect because traceable corrections support accurate records.
• D preserves both the corrected information and the history of the correction.

Before changing a value, establish the supporting evidence. An audit trail cannot make an unsupported guess accurate.

Question 4: An immediate hazard requires a deviation

During a trial visit, an investigator identifies an immediate hazard to a participant. Waiting for an amendment to be approved would prolong that hazard. Which action is most consistent with GCP?

A. Make the necessary protective deviation, document it, promptly inform the sponsor, and report the hazard and change to the IRB/IEC and authorities where applicable.

B. Follow the protocol regardless of the immediate hazard.

C. Make the change but omit documentation because it was justified.

D. Permanently change the protocol for all participants without further review.

Best answer: A. Annex 1 sections 2.5.3–2.5.5 address documented deviations, immediate-hazard protection, and subsequent communications.

• A combines immediate protection with documentation and reporting.
• B treats protocol compliance as overriding participant protection.
• C confuses a justified deviation with an undocumented one.
• D expands an urgent protective action into an unrestricted protocol amendment.

The exception is tied to an immediate hazard. Convenience, workload, and missed visit targets do not establish that condition.

Question 5: Sponsor oversight after outsourcing

A sponsor contracts with a service provider for trial data management. The agreement specifies the transferred activities. A manager proposes stopping sponsor oversight because the provider has extensive experience. What is the best response?

A. Agree, because the contract transfers all sponsor responsibility.

B. Require identical monitoring of every activity regardless of risk.

C. Maintain documented, proportionate oversight of the transferred activities and the provider's performance.

D. Review performance only after a regulatory inspection finds a problem.

Best answer: C. Annex 1 section 3.6 addresses documented agreements and transferred activities; section 3.9 addresses sponsor oversight tailored to trial complexity and risk.

• A mistakes transfer of activities for removal of sponsor responsibility.
• B ignores proportionality and the importance of risks to participants and reliable results.
• C preserves responsibility while directing oversight toward relevant risks.
• D postpones oversight until an external failure signal arrives.

Turn explanations into better practice

For each missed item, write the role, the triggering fact, and the governing section. Then explain why the strongest distractor fails. Revisit the rule with one changed fact rather than memorizing the answer letter.

Passumi's first 25% of each available paper is free, rounded up to a whole question. A preview result is partial and should not be treated as a complete examination score or a pass prediction.

Official sources

Checked October 15, 2026: ACRP Certification Handbook, ACRP exam preparation references, the linked ACRP calendar and transition notices, and ICH E6(R3), Principles and Annex 1. These original educational scenarios are independent adaptations of GCP principles; ICH and ACRP do not endorse them.